Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Belarte Tornero, Laia Carla
- dc.contributor.author Mojón Álvarez, Diana
- dc.contributor.author Solé-González, Eduard
- dc.contributor.author Ruiz-Bustillo, Sonia
- dc.contributor.author Valdivielso Moré, Sandra
- dc.contributor.author Farré López, Núria
- dc.date.accessioned 2022-06-29T06:10:27Z
- dc.date.issued 2021
- dc.format.mimetype application/pdf
- dc.identifier.citation Belarte-Tornero LC, Mojón D, Solé-González E, Ruiz-Bustillo S, Valdivielso-More S, Farré N. Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9. DOI: 10.1016/j.rec.2021.06.005
- dc.identifier.doi http://dx.doi.org/10.1016/j.rec.2021.06.005
- dc.identifier.issn 1885-5857
- dc.identifier.uri http://hdl.handle.net/10230/53629
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9
- dc.rights © Elsevier http://dx.doi.org/10.1016/j.rec.2021.06.005
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.title Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction
- dc.title.alternative El sacubitrilo-valsartán modifica la indicación de dispositivos implantables en pacientes con insuficiencia cardiaca y fracción de eyección reducida
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion